Board Meeting
4 May 2026
Purposeβ
Formulation of the annual accounts for the financial year 2025 (Art. 253 LSC). The full set of annual accounts (ECPN and memoria abreviada included) has been circulated to board members in advance for review; in this session only the Balance and P&L will be walked through. The auditor's report is scheduled for after formulation.
Agendaβ
- Welcome and openingVerification of quorum and delegation of vote on file
- Review of the agenda
- Formulation of the 2025 annual accounts
- Walk-through of the Balance Sheet at 31 December 2025
- Walk-through of the Profit and Loss statement
- ECPN and memoria abreviada: previously circulated, available for questions
- Proposed allocation of the 2025 resultProposal to apply the 2025 loss against prior-year results (cuenta 121, "Resultados negativos de ejercicios anteriores")
- Vote on the formulation of the 2025 annual accounts (Art. 253 LSC)
- Motion: formulation of the full set of 2025 annual accounts and proposed allocation of result
- Vote of D.Βͺ Sheyla Andina Aguilar Robles, in own right and on behalf of D. Alfonso Medela Ayarzaguena (delegation of vote, Art. 248 LSC)
- Vote of D. Andres Sanchez Hontoria
- Signature by the board members on the formulated documents
- Open floor
- Closing of the meeting
Resolutions adoptedβ
The Board unanimously resolved:
- Formulation of the 2025 annual accounts (Art. 253 LSC) in abbreviated format, comprising abbreviated Balance Sheet, abbreviated Profit and Loss Statement, and Notes to the Financial Statements (Memoria), in the terms of the dossier presented.
- Allocation of the 2025 result: the loss of the financial year, amounting to 517.357 euros, is fully applied against prior-year results (account 121, "Resultados negativos de ejercicios anteriores").
- Signature of the formulated documents by the directors, in compliance with Art. 253.2 LSC. The documents are circulated for signature following the meeting.
Vote: unanimous, with three votes in favor (D.Βͺ Sheyla Andina Aguilar Robles in own right and on behalf of D. Alfonso Medela Ayarzaguena by delegation under Art. 248 LSC, and D. Andres Sanchez Hontoria).
Headline figures of the formulated accountsβ
Balance Sheet at 31 December 2025
| Magnitude | 2025 | 2024 |
|---|---|---|
| Total assets | 5.67M⬠| 5.63M⬠|
| Equity | 4.41M⬠| 5.13M⬠|
| Intangible assets | 3.19M⬠| 2.75M⬠|
| Capitalised CDTI grants (within equity) | 2.28M⬠| 2.48M⬠|
Profit and Loss Statement
| Magnitude | 2025 | 2024 | Ξ |
|---|---|---|---|
| Revenue (Cifra de negocios) | 604.495β¬ | 326.208β¬ | +85% |
| Capitalised internal R&D work | 632.058β¬ | 1.746.652β¬ | -64% |
| Personnel expenses | -1.346.107β¬ | -1.047.736β¬ | +28% |
| Result before tax | -646.697β¬ | -304.108β¬ | |
| Result for the year | -517.357β¬ | +244.512β¬ |
Attendeesβ
Board membersβ
| Name | Role | Representing | Attendance |
|---|---|---|---|
| D.Βͺ Sheyla Andina Aguilar Robles | Chair | Legit.Health | Present |
| D. Andres Sanchez Hontoria | Member | Mutua Ventures SAU | Present |
| D. Alfonso Medela Ayarzaguena | Secretary | Legit.Health | Represented by D.Βͺ Sheyla Andina Aguilar Robles by virtue of delegation of vote (Art. 248 LSC) |
Guestsβ
| Name | Role | Organization |
|---|---|---|
| Iker Camara | CFO | Legit.Health |
| Idoia Garro | Accountant | Legit.Health |
| Borja AgustΓn CortΓ©s | Guest | Mutua Ventures SAU |
Observersβ
| Name | Organization |
|---|---|
| Taig Mac Carthy | Legit.Health |